nitazoxanide has been researched along with Chagas Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delgado-Enciso, I; Dobrovinskaya, O; Espinoza-Gómez, F; López-Lemus, UA; Melnikov, V; Pimientel-Rodrigez, V; Rodriguez-Hernández, A; Rueda-Valdovinos, G; Valle-Reyes, JS; Wookee-Zea, C | 1 |
| Campbell-Lendrum, D; Castillo-Riquelme, M; Chalabi, Z; Davies, C; Fox-Rushby, J; Guhl, F; Lord, J | 1 |
2 other study(ies) available for nitazoxanide and Chagas Disease
| Article | Year |
|---|---|
Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Topics: Animals; Chagas Disease; Disease Models, Animal; Heart; Male; Mice, Inbred BALB C; Muscle, Striated; Myocardium; Nitro Compounds; Parasitemia; Thiazoles; Trypanocidal Agents; Trypanosoma cruzi | 2017 |
Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: the example of Chagas disease.
Topics: Chagas Disease; Communicable Diseases; Cost-Benefit Analysis; Geography; Health Policy; Infection Control; Models, Econometric; Nitro Compounds; Thiazoles | 2008 |